These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23591286)

  • 1. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission.
    Singal AG; Rahimi RS; Clark C; Ma Y; Cuthbert JA; Rockey DC; Amarasingham R
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1335-1341.e1. PubMed ID: 23591286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
    Hu XP; Gao J
    World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic medical record-based multicondition models to predict the risk of 30 day readmission or death among adult medicine patients: validation and comparison to existing models.
    Amarasingham R; Velasco F; Xie B; Clark C; Ma Y; Zhang S; Bhat D; Lucena B; Huesch M; Halm EA
    BMC Med Inform Decis Mak; 2015 May; 15():39. PubMed ID: 25991003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort.
    Patel R; Poddar P; Choksi D; Pandey V; Ingle M; Khairnar H; Sawant P
    Ann Hepatol; 2019; 18(1):30-39. PubMed ID: 31113606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data.
    Amarasingham R; Moore BJ; Tabak YP; Drazner MH; Clark CA; Zhang S; Reed WG; Swanson TS; Ma Y; Halm EA
    Med Care; 2010 Nov; 48(11):981-8. PubMed ID: 20940649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting 30-day readmissions with preadmission electronic health record data.
    Shadmi E; Flaks-Manov N; Hoshen M; Goldman O; Bitterman H; Balicer RD
    Med Care; 2015 Mar; 53(3):283-9. PubMed ID: 25634089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.
    Mudireddy P; Scott F; Feathers A; Lichtenstein GR
    Inflamm Bowel Dis; 2017 Oct; 23(10):1832-1839. PubMed ID: 28858068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admission Data Predict High Hospital Readmission Risk.
    Logue E; Smucker W; Regan C
    J Am Board Fam Med; 2016; 29(1):50-9. PubMed ID: 26769877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days.
    Xu X; Tan J; Wang H; Zhao W; Qin B
    Front Med (Lausanne); 2021; 8():646875. PubMed ID: 34136498
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of administrative claims data for identifying patients with cirrhosis.
    Nehra MS; Ma Y; Clark C; Amarasingham R; Rockey DC; Singal AG
    J Clin Gastroenterol; 2013; 47(5):e50-4. PubMed ID: 23090041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and validation of a hospital all-cause 30-day readmission index.
    Franckowiak TM; Raub JN; Yost R
    Am J Health Syst Pharm; 2019 Mar; 76(7):436-443. PubMed ID: 31361822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quick chronic liver failure-sequential organ failure assessment: an easy-to-use scoring model for predicting mortality risk in critically ill cirrhosis patients.
    Zhou XD; Zhang JY; Liu WY; Wu SJ; Shi KQ; Braddock M; Chen YP; Huang WJ; Zheng MH
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):698-705. PubMed ID: 28240612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis.
    Tapper EB; Finkelstein D; Mittleman MA; Piatkowski G; Lai M
    Hepatology; 2015 Aug; 62(2):584-90. PubMed ID: 25846824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Wei M; Ford J; Li Q; Jeong D; Kwong AJ; Nguyen MH; Chang MS
    Dig Dis Sci; 2018 Sep; 63(9):2267-2274. PubMed ID: 29457210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic medical record-based model to predict the risk of 90-day readmission for patients with heart failure.
    Tan BY; Gu JY; Wei HY; Chen L; Yan SL; Deng N
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):193. PubMed ID: 31615569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of Cirrhosis Best Practices Into Electronic Medical Record Documentation Associated With Reduction in 30-Day Mortality Following Hospitalization.
    Sherman Z; Wahid N; Wagner M; Soltani A; Rosenblatt R; Fortune B; Lucero C; Schoenfeld E; Brown R; Jesudian A
    J Clin Gastroenterol; 2023 Oct; 57(9):951-955. PubMed ID: 36730665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.
    Cervoni JP; Amorós À; Bañares R; Luis Montero J; Soriano G; Weil D; Moreau R; Pavesi M; Thévenot T; Di Martino V;
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1028-34. PubMed ID: 27271159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Model Based on Health Data Analysis for Risk of Readmission in Disease-Specific Cohorts.
    Ansari MS; Alok AK; Jain D; Rana S; Gupta S; Salwan R; Venkatesh S
    Perspect Health Inf Manag; 2021; 18(Spring):1j. PubMed ID: 34035791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Electronic Medical Record and Self-Administered Medication Risk Screening Tools in a Primary Care Clinic.
    Makowsky MJ; Cor K; Wong T
    J Manag Care Spec Pharm; 2017 May; 23(5):566-572. PubMed ID: 28448775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis.
    Chirapongsathorn S; Bunraksa W; Chaiprasert A; Punpanich D; Supasyndh O; Kamath PS
    J Gastroenterol Hepatol; 2018 Mar; 33(3):726-732. PubMed ID: 28840619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.